Ophthalmics

Pleiad has developed expertise in ophthalmology by virtue of running many ophthalmic trials and inheriting the legacy experience of its staff.

Approximately 50% of Pleiad's ophthalmology trials are of medical devices or diagnostics, and the rest are of pharmaceutical products. It is noteworthy that ophthalmic implants such as intra-ocular lenses are predicted to be the third largest segment of implanted devices by 2014, worth around $1.5 billion. This ties in nicely with Pleiad's expertise in ophthalmics and implanted medical devices.

As in most therapy areas, the devil lies in the details of clinical assessments, data collection, and monitoring. Many of our specialist ophthalmology staff were originally ophthalmic technicians and/or coordinators at ophthalmology sites. So their monitoring is particularly effective and they are able to understand and interpret data rather than just checking them.